PP
BSTC

Paloma Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Paloma Partners’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-21,365
Closed -$333K – 1278
2013
Q2 		$333K Buy
+21,365
New +$344K 0.02% 613

Other funds holding BSTC

BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
MOACM
Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Paloma Partners's BSTC Position: Q3 2013 in Review

Paloma Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2013, closing a stake of 21,365 shares — an estimated $333K sold.

Paloma Partners first reported a position in BSTC in Q2 2013 and held it in 1 quarter. The position peaked at $333K in Q2 2013. 41 funds tracked by Wall St. Rank hold BSTC as of Q3 2013.

  • Paloma Partners reported no remaining BioSpecifics Technologies Corp. position as of Q3 2013 after selling out during the quarter.
  • Paloma Partners sold 21,365 BioSpecifics Technologies Corp. shares in Q3 2013, an estimated $333K.
  • Paloma Partners first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 1 quarter.
  • Paloma Partners's BioSpecifics Technologies Corp. position peaked at $333K in Q2 2013.
  • 41 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2013.

Based on Paloma Partners's 13F filing for Q3 2013, filed 14 Nov 2013.